Moving from 4mg to 8mg of Astaxanthin.


In the 2026 "Precision Immunometabolism" framework, 8mg of Astaxanthin is often viewed as the "Therapeutic Threshold" where the molecule stops being just a nutrient and starts functioning as a "Structural Sealant" for high-risk profiles like yours.

The 2026 Justification for 8mg

1. The "Triple Positive" Shield (Oxidized-LDL Reduction)

Recent 2025–2026 data indicates that while 4mg provides a baseline antioxidant effect, 8mg is required to significantly extend the LDL oxidation lag time.

  • The APS Link: For a Triple Positive patient, preventing the oxidation of $\beta_2$-Glycoprotein I and LDL is the primary goal. At 8mg, the "slickness" of your endothelium increases, making it much harder for antibodies to find a "sticky" spot on your blood vessel walls.

2. The "Nrf2 Handshake" (Synergy with Prostaphane)

Contrary to the old fear that antioxidants might blunt the "janitor" (Nrf2), 2026 research shows that Astaxanthin actually promotes Nrf2 nuclear translocation.

  • The Synergy: By taking 8mg, you aren't muzzling your Prostaphane (Sulforaphane); you are providing a "cleaner workspace" for the Nrf2 pathways to function. The Astaxanthin handles the immediate peroxide "flash" from your $SOD2$ (AA) hardware, allowing the Nrf2 system to focus on long-term detox and enzyme production ($GSTM1$ support).

3. Sealing the $MFN2$ (TT) Shards

Your $MFN2$ (TT) hardware makes your platelets prone to fragmentation. At 8mg, the density of Astaxanthin within the mitochondrial membrane is nearly double. This creates a more robust "physical rebar" that prevents the leakage of mitochondrial DNA (mtDNA)—the primary signal that triggers the cGAS-STING alarm and drops your platelet count.


References

https://pmc.ncbi.nlm.nih.gov/articles/PMC12189495/#:~:text=Studies%20have%20shown%20that%20AST,oxygenase%2D1%2C%20and%20SOD1.


https://www.researchgate.net/publication/400886910_Astaxanthin_suppresses_thrombosis_by_inhibiting_both_platelet_activation_and_blood_coagulation#:~:text=Conclusion%20and%20Implications%20ASX%20exhibits,novel%20strategy%20for%20thrombosis%20prevention.

Comments

Post a Comment

Popular posts from this blog

Kicking six years of chronic fatigue and how I accidently became a biohacker.

Kicking six years of chronic fatigue and how I accidently became a biohacker. After 5 years of low but stable platelets, I realised that I needed to address my chronic fatigue. Both my GP and haematologist have both constantly told me that there is no clinical reason they know of why I should be experiencing chronic fatigue. In the past, I have pointed out to both medics that the majority of Antiphospholipid Syndrome (APS) and Immune Thrombocytopenia (ITP) patients identify as living with chronic fatigue when surveyed by their respective patient support associations. In autumn 2025, I decided that I would explore the vast array of supplements and try some which could possibly help and yet crucially wouldn't worsen my autoimmune conditions or put me at any greater risk of bleeding or thrombosis. Although I normally sleep between 8 or 9 hours each night, I still wake up feeling exhausted and this fatigue continues through many days. Sleep trackers tell me that I am getting insufficie...
Read more
  🕒 The Optimized Daily Protocol (Revised Feb 2026 - V11) 🌅 1. Upon Waking (Empty Stomach) Iron (3x / Week): Ferrum Hausmann (100mg) Purpose & Genetics: Supports oxygen transport and energy production; your 105 µg/L Ferritin shows this frequency is maintaining a stable baseline without overloading. Autoimmune/Interactions: Isolated here to prevent calcium and zinc (from your multivitamin) from blocking its uptake via the DMT1 transporter. Biocyte Liposomal Glutathione (200mg) Purpose & Genetics: The "Master Antioxidant" that compensates for potential genetic antioxidant gaps by neutralizing mitochondrial reactive oxygen species (ROS). Autoimmune/Interactions: Crucial for APS to reduce systemic oxidative stress; liposomal form bypasses gut degradation for superior bioavailability. VeLife Magnesium L-Threonate (1334mg) Purpose & Genetics: Specifically engineered to cross the blood-brain barrier to support synaptic density and cognitive mitochondrial health. A...
Read more

Beyond Autoimmunity: My Mitochondrial "Hardware" and the Genetic Logic of My ITP/APS Protocol

Beyond Autoimmunity: My Mitochondrial "Hardware" and the Genetic Logic of My ITP/APS Protocol ​Most people view Antiphospholipid Syndrome (APS) and Immune Thrombocytopenia (ITP) purely as "software" issues—the immune system has a glitch and is attacking healthy cells. But after diving deep into my 23andMe raw data, I’ve discovered that the "hardware"—my mitochondria—might be the one sending the distress signal in the first place. ​I’ve mapped out my "Genomic Blueprint" to understand why my platelets stay in the 80k–110k range and why my "Triple Positive" profile requires such a specific protocol. Here is the breakdown of what I found. ​ 1. Why my platelets "retire" early ​I discovered that I have a significant bottleneck in Mitofusin 2 (MFN2) . ​ The Marker: rs1474868 (T/T) ​ The Implication: This genotype is linked to reduced MFN2 expression in platelets. Without it, my platelet mitochondria fragment easily and can...
Read more